Identification of formononetin as the active compound of CR‐SR in hepatocellular carcinoma treatment: An integrated approach combining network pharmacology and weighted gene co‐expression networks.

Autor: Li, Chun¹ (AUTHOR), Xie, Yuxin² (AUTHOR), Hu, Shaoyu³ (AUTHOR), Yu, Hong² (AUTHOR), Xu, Yunke⁴ (AUTHOR), Shen, Hongping¹ (AUTHOR), Yuan, Yuan¹ (AUTHOR), Gu, Long⁵ (AUTHOR) gulong@swmu.edu.cn, Pu, Bangming⁴ (AUTHOR) pbm1103@swmu.edu.cn

Publikováno v: Chemical Biology & Drug Design. Jan2024, Vol. 103 Issue 1, p1-16. 16p.

Formononetin triggers ferroptosis in triple-negative breast cancer cells by regulating the mTORC1/SREBP1/SCD1 pathway.

Autor: Dong Xie, Yulang Jiang, Huan Wang, Lingyi Zhu, Shuangqin Huang, Sheng Liu, Weihong Zhang, Tian Li

Publikováno v: Frontiers in Pharmacology; 2024, p1-14, 14p

METABOLOMICS PERSPECTIVE OF MEDICINAL PLANTS IN TREATMENT OF COLORECTAL CANCER (CRC): A REVIEW.

Autor: Raghuvanshi, P., Chourdia, S., Garg, G.

Publikováno v: Journal of the Pakistan Medical Association; May2024, Vol. 74 Issue 5, p74-80, 7p

Combination of Formononetin and Sulforaphane Natural Drug Repress the Proliferation of Cervical Cancer Cells via Impeding PI3K/AKT/mTOR Pathway.

Autor: Jiang P; Gynaecology and Obstetrics, Yantai Mountain Hospital, Yantai, 264005, China., Jiang W; Medical Department, Jinan Maternity and Child Care Hospital, Jinan, 250000, China., Li X; Delivery Room, Jinan Maternity and Child Care Hospital, Jinan, 250000, China., Zhu Q; Delivery Room, Jinan Maternity and Child Care Hospital, Jinan, 250000, China. zql3686@outlook.com.

Publikováno v: Applied biochemistry and biotechnology [Appl Biochem Biotechnol] 2024 Oct; Vol. 196 (10), pp. 6726-6744. Date of Electronic Publication: 2024 Feb 24.

Uncovering the Mechanism of Astragalus membranaceus in the Treatment of Diabetic Nephropathy Based on Network Pharmacology.

Autor: Guo, Ming-Fei¹ (AUTHOR), Dai, Ya-Ji² (AUTHOR), Gao, Jia-Rong³ (AUTHOR), Chen, Pei-Jie¹ (AUTHOR)

Publikováno v: Journal of Diabetes Research. 3/6/2020, p1-13. 13p.